| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/23/2005 | CN1596881A Application Hehoupu phenol in preparing antitumour multi medicinal tolerant medicine |
| 03/23/2005 | CN1596878A Oral medicine possessing colon orientation medicine releasing function |
| 03/23/2005 | CN1194093C Bacterial plasmids |
| 03/23/2005 | CN1194003C Small RNA molecule for inhibiting SARS virus infestion |
| 03/23/2005 | CN1194002C Shortened-chain polynucleotide and process for the preparation thereof |
| 03/23/2005 | CN1193996C Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent |
| 03/23/2005 | CN1193991C Method for preparing 2.5-diamino-4.6-dichloropyrimidine |
| 03/23/2005 | CN1193801C Method for preparing tissue engineering cell cytoskeletay and products obtained by said method |
| 03/23/2005 | CN1193793C Diarylprophin photosensitizer and its preparing process and usage |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193786C Preparation of Chinese herbal medicine for treating cold injury, various indurations and swelling, pain as well as its preparing method |
| 03/23/2005 | CN1193783C External used medicine against piles |
| 03/23/2005 | CN1193781C Medicine for treating aphtha |
| 03/23/2005 | CN1193779C Traditional chinese medicine suppository for treating vaginitis and its preparing method |
| 03/23/2005 | CN1193769C Health-care food with sobering function |
| 03/23/2005 | CN1193768C Artificial tear |
| 03/23/2005 | CN1193767C Medicine formed form ganglioside and erigeron breviscapus extract and health-care product and their application |
| 03/23/2005 | CN1193766C Gardenia total glydcoside composite for treating hepatitis and its preparation method |
| 03/23/2005 | CN1193765C Use of 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-one-4H-1 benzopyrany 1-7-hydroxy-beta-D-glucuronic acid in producing medicine |
| 03/23/2005 | CN1193764C Novel medicinal use and prepn process of steroid general saponin of Rhizomz Anemarrhenae as Chinese medicine |
| 03/23/2005 | CN1193763C Rhodiola total tanning matter extract and use for preparing medicine for treating senile dementia |
| 03/23/2005 | CN1193762C Efficient biological lubricant and preparation method chereof |
| 03/23/2005 | CN1193761C Controllable release system of glucocorticoid and its preparation method |
| 03/23/2005 | CN1193760C Licorzinc solution composition, preparation process tereof and licorxinc preparation |
| 03/23/2005 | CN1193759C Sustained release and implantation type cis-platinum medicine and method for preparing same |
| 03/23/2005 | CN1193758C Preparation of theophylline or aminophylline supplied through skin for treating respiratory disease as well as its preparing method |
| 03/23/2005 | CN1193757C Sustained release ranolazine formulations |
| 03/23/2005 | CN1193756C SGK2 and SGK3 used as diagnostic and therapeutic targets |
| 03/23/2005 | CN1193755C Fast disintegrated and stripped oral cilostazol tablt and its prepn process |
| 03/23/2005 | CN1193754C Sustained release oral preparations |
| 03/23/2005 | CN1193753C Ginkgo leaf extract and injection fluid containing same |
| 03/23/2005 | CN1193752C Tetrahydrolipstatin-containing compositions |
| 03/23/2005 | CN1193751C Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives |
| 03/23/2005 | CN1193750C Medicine for treating menopausal syndrome |
| 03/23/2005 | CN1193749C Bladder irrigation original liguid |
| 03/23/2005 | CN1193748C Gardos channel antagonists |
| 03/23/2005 | CN1193747C Diphenyl ketoaldehyde derivatives with anti-HIV activity |
| 03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
| 03/23/2005 | CN1193743C Multilayer pharmaceutical product for release in the colon |
| 03/23/2005 | CN1193741C Preparation method of water soluble anticancer medical microsphere |
| 03/23/2005 | CN1193730C Use of glyceryl triacetate for treating onychomycoses |
| 03/22/2005 | US6870070 Hydrogenation, resoulution, alkylation, bromination, andcarboxamidation |
| 03/22/2005 | US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents |
| 03/22/2005 | US6870052 Preparation of thioarabinofuranosyl compounds and use thereof |
| 03/22/2005 | US6870042 Mutants of streptococcal toxin A and methods of use |
| 03/22/2005 | US6870031 Haemopoietin receptor and genetic sequences encoding same |
| 03/22/2005 | US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 03/22/2005 | US6869976 Dispersion or complexes of calcium sulfate in polymers such as polyethylene glycol or dextran sulfate; is a solid matrix due to hydration; especially containing an antibiotic for treating bone disorders |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/22/2005 | US6869972 Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use |
| 03/22/2005 | US6869970 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents |
| 03/22/2005 | US6869969 Isoxazole estrogen receptor agonist and antagonist |
| 03/22/2005 | US6869968 Such as 3-(4-fluorophenyl)-4-(4-methysulphonylphenyl)-2-(3H)-oxazolone; for treating colorectal cancer, fevers, and inflammation |
| 03/22/2005 | US6869965 Such as 2-methylpropyl-(4-bromo-3-fluorophenyl)carbamate |
| 03/22/2005 | US6869964 Inhibiting NS3 (non-structural proteins) proteases; tripeptides |
| 03/22/2005 | US6869963 Stable pharmaceutical compositions containing an ACE inhibitor |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/22/2005 | US6869961 Store operated calcium influx inhibitors and methods of use |
| 03/22/2005 | US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine) |
| 03/22/2005 | US6869959 Heterocyclic carboxylic acid derivatives |
| 03/22/2005 | US6869956 Such as 4-(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline; kits; treating arthritis, psoriasis, inflammatory bowel disease, autoimmune diseases and neurodegenerative diseases among others |
| 03/22/2005 | US6869955 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders |
| 03/22/2005 | US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/22/2005 | US6869953 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869949 Such as 8-hydroxy-2,3-dimiethyl-9-(3-thienyl)-7,8,9,10-tetrahydroimidazo(1,2 -h)(1,7)napththyridin-7-one |
| 03/22/2005 | US6869946 For therapy of disease or condition in a mammal, wherein the alpha 7 nicotinic acetylcholine receptor is implicated and for therapy of diseases where there is a sensory-gating deficit in a mammal |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869944 Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| 03/22/2005 | US6869943 Sorbitol dehydrogenase inhibitors |
| 03/22/2005 | US6869942 Comprises formoterol and corticosteroid; for use in treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease |
| 03/22/2005 | US6869941 Combination of drospirenone and an estrogen sulphamate for HRT |
| 03/22/2005 | US6869940 Administering an active vitamin D or a derivative thereof as an active ingredient for inhibiting bone metastasis of a malignant tumor in a patient who has a cancer excluding breast cancer |
| 03/22/2005 | US6869939 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
| 03/22/2005 | US6869935 Gene Therapy for proliferative vitreoretinopathy |
| 03/22/2005 | US6869929 Autoimmune disease; cardiovascular disorders; rheumatic disorders |
| 03/22/2005 | US6869789 Heparinase III and uses thereof |
| 03/22/2005 | US6869623 Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil |
| 03/22/2005 | US6869622 Extracts of the root of a plant of the family Valerianacae for use in therapy of sleep disorders |
| 03/22/2005 | US6869621 Diet composition comprising raw foods and dietary fibers |
| 03/22/2005 | US6869618 Process for preparing tannate liquid and semi-solid dosage forms |
| 03/22/2005 | US6869617 Dissolving the organic compound in the water-miscible first solvent to form a solution, mixing solution with second solvent to define a pre-suspension; adding energy to the pre-suspension to form particles |
| 03/22/2005 | US6869615 Enterically coated to prevent gastrointestinal side effects |
| 03/22/2005 | US6869611 Composition and method of effecting superficial chemical skin peels |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/22/2005 | US6869603 A kit containing the enzyme lipoprotein lipase in a stabilized form in a container and a topical formulation of monoglycerides, diglycerides or triglycerides of synthetic, plant or animal origin for application to human skin |
| 03/22/2005 | CA2379672C Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 03/22/2005 | CA2330092C Benzimidazole compounds as orl1-receptor agonists |
| 03/22/2005 | CA2312234C Use of methylnaltrexone and related compounds |
| 03/22/2005 | CA2257772C Bicyclic¬3.1.0|hexanes and related compounds |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/22/2005 | CA2178219C Substituted morpholine derivatives and their use as therapeutic agents |
| 03/22/2005 | CA2125189C Pyropheophorbides and their use in photodynamic therapy |
| 03/18/2005 | CA2441710A1 Oral rinse |
| 03/17/2005 | WO2005024603A2 Methods for detecting, diagnosing and treating human renal cell carcinoma |
| 03/17/2005 | WO2005023990A2 Trans-splicing mediated photodynamic therapy |
| 03/17/2005 | WO2005023931A1 Biocidal polymers |
| 03/17/2005 | WO2005023896A2 Purified polyoxypropylene/polyoxyethylene copolymers and method of preparing the same |